Seppi K - Search Results

1

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

Iranzo A, Lomeña F, Stockner H, Valldeoriola F, Vilaseca I, Salamero M, Molinuevo JL, Serradell M, Duch J, Pavía J, Gallego J, Seppi K, Högl B, Tolosa E, Poewe W, Santamaria J; Sleep Innsbruck Barcelona (SINBAR) group. Iranzo A, et al. Among authors: seppi k. Lancet Neurol. 2010 Nov;9(11):1070-7. doi: 10.1016/S1474-4422(10)70216-7. Epub 2010 Sep 16. Lancet Neurol. 2010. PMID: 20846908

2

Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).

Puschban Z, Waldner R, Seppi K, Stefanova N, Humpel C, Scherfler C, Levivier M, Poewe W, Wenning GK. Puschban Z, et al. Among authors: seppi k. Exp Neurol. 2000 Jul;164(1):166-75. doi: 10.1006/exnr.2000.7422. Exp Neurol. 2000. PMID: 10877927

3

No functional effects of embryonic neuronal grafts on motor deficits in a 3-nitropropionic acid rat model of advanced striatonigral degeneration (multiple system atrophy).

Waldner R, Puschban Z, Scherfler C, Seppi K, Jellinger K, Poewe W, Wenning GK. Waldner R, et al. Among authors: seppi k. Neuroscience. 2001;102(3):581-92. doi: 10.1016/s0306-4522(00)00500-5. Neuroscience. 2001. PMID: 11226695

4

Striatal dopamine transporter function in dementia with Lewy bodies and Parkinson's disease.

Ransmayr G, Seppi K, Donnemiller E, Luginger E, Marksteiner J, Riccabona G, Poewe W, Wenning GK. Ransmayr G, et al. Among authors: seppi k. Eur J Nucl Med. 2001 Oct;28(10):1523-8. doi: 10.1007/s002590100571. Eur J Nucl Med. 2001. PMID: 11685496

5

Riluzole in Huntington's disease (HD): an open label study with one year follow up.

Seppi K, Mueller J, Bodner T, Brandauer E, Benke T, Weirich-Schwaiger H, Poewe W, Wenning GK. Seppi K, et al. J Neurol. 2001 Oct;248(10):866-9. doi: 10.1007/s004150170071. J Neurol. 2001. PMID: 11697523 Clinical Trial.

6

Treatment options for depression and psychosis in Parkinson's disease.

Poewe W, Seppi K. Poewe W, et al. Among authors: seppi k. J Neurol. 2001 Sep;248 Suppl 3:III12-21. doi: 10.1007/pl00007821. J Neurol. 2001. PMID: 11697683 Review.

7

Irresistible onset of sleep during acute levodopa challenge in a patient with multiple system atrophy (MSA): placebo-controlled, polysomnographic case report.

Högl B, Seppi K, Brandauer E, Wenning G, Poewe W. Högl B, et al. Among authors: seppi k. Mov Disord. 2001 Nov;16(6):1177-9. doi: 10.1002/mds.1207. Mov Disord. 2001. PMID: 11748758 Clinical Trial.

8

Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD.

Schocke MF, Seppi K, Esterhammer R, Kremser C, Jaschke W, Poewe W, Wenning GK. Schocke MF, et al. Among authors: seppi k. Neurology. 2002 Feb 26;58(4):575-80. doi: 10.1212/wnl.58.4.575. Neurology. 2002. PMID: 11865135

9

Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystonia.

Müller J, Wenning GK, Wissel J, Seppi K, Poewe W. Müller J, et al. Among authors: seppi k. J Neurol. 2002 Mar;249(3):300-4. doi: 10.1007/s004150200009. J Neurol. 2002. PMID: 11993530 Clinical Trial.

10

The prevalence of primary dystonia in the general community.

Müller J, Kiechl S, Wenning GK, Seppi K, Willeit J, Gasperi A, Wissel J, Gasser T, Poewe W. Müller J, et al. Among authors: seppi k. Neurology. 2002 Sep 24;59(6):941-3. doi: 10.1212/01.wnl.0000026474.12594.0d. Neurology. 2002. PMID: 12297587

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters